(Q44377152)

2 December 2017

title

Low NDRG1 mRNA expression predicts a poor prognosis in neuroblastoma patients (English)

1 reference

2 December 2017

1 reference

Kohei Matsushita

1

1 reference

2 December 2017

Keiichi Uchida

2

1 reference

2 December 2017

Susumu Saigusa

3

1 reference

2 December 2017

Shozo Ide

4

1 reference

2 December 2017

Kiyoshi Hashimoto

5

1 reference

2 December 2017

Yuhki Koike

6

1 reference

2 December 2017

Kohei Otake

7

1 reference

2 December 2017

Mikihiro Inoue

8

1 reference

2 December 2017

Koji Tanaka

9

1 reference

2 December 2017

Masato Kusunoki

10

1 reference

2 December 2017

publication date

1 April 2013

1 reference

Pediatric Surgery International

2 December 2017

published in

1 reference

2 December 2017

volume

29

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

363-368

1 reference

Treatment results and prognostic factors of pediatric neuroblastoma: a retrospective study

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00383-012-3248-6

Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-012-3248-6

Prognostic value of MYCN and ID2 overexpression in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-012-3248-6

Expression of NDRG1, a differentiation-related gene, in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-012-3248-6

Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-012-3248-6

NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-012-3248-6

Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-012-3248-6

HsMAD2 mRNA expression may be a predictor of sensitivity to paclitaxel and survival in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-012-3248-6

Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-012-3248-6

The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-012-3248-6

Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-012-3248-6

Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-012-3248-6

Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-012-3248-6

Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-012-3248-6

Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-012-3248-6

N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-012-3248-6

Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-012-3248-6

Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma.

21 January 2018

1 reference

12 December 2020

Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer

1 reference

12 December 2020

The Drg-1 gene suppresses tumor metastasis in prostate cancer.

1 reference

12 December 2020

A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms

1 reference

12 December 2020

Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma

1 reference

12 December 2020

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

1 reference

12 December 2020

1 reference

12 December 2020

MYCN protein expression as a predictor of neuroblastoma prognosis.

1 reference

12 December 2020

Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.

1 reference

12 December 2020

10.1007/S00383-012-3248-6

Identifiers

DOI

1 reference

2 December 2017

1 reference